Breakthrough Drug Shows Promise for Children with Rare Epilepsy
A clinical trial in England has demonstrated remarkable success in treating children with Dravet syndrome, a rare form of treatment-resistant epilepsy. The experimental drug Zorevunersen reduced seizures by 80 percent after three doses, offering hope for thousands of children with genetic epilepsies.